temozolomide has been researched along with Intestinal Diseases in 1 studies
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tentori, L | 1 |
| Leonetti, C | 1 |
| Scarsella, M | 1 |
| Muzi, A | 1 |
| Mazzon, E | 1 |
| Vergati, M | 1 |
| Forini, O | 1 |
| Lapidus, R | 1 |
| Xu, W | 1 |
| Dorio, AS | 1 |
| Zhang, J | 1 |
| Cuzzocrea, S | 1 |
| Graziani, G | 1 |
1 other study available for temozolomide and Intestinal Diseases
| Article | Year |
|---|---|
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Proliferation; Colonic Neoplasms; | 2006 |